InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

122
Insider
Date
Role
Action
Shares
Price
Amount
Jerome Benedict Durso
13 Aug 2026
President and CEO
Buy
15,000
$2.95
$44.25K
John Gill
6 Apr 2026
Director
Buy
9,200
$3.41
$31.35K
Jerome Benedict Durso
1 Apr 2026
President and CEO
Buy
15,000
$3.14
$47.10K
Gregory L Weaver
1 Apr 2026
Chief Financial Officer
Buy
10,000
$3.15
$31.50K
Jerome Benedict Durso
6 Mar 2026
President and CEO
Buy
20,000
$3.54
$70.79K
Gregory L Weaver
6 Mar 2026
Chief Financial Officer
Buy
5,000
$3.54
$17.70K
Wayne Pisano
8 Jan 2026
Director
Buy
5,000
$4.08
$20.41K
Catherine A. Sohn
5 Jan 2026
Director
Buy
500
$4.24
$2.12K
Diane Jorkasky
29 Dec 2025
Director
Buy
527
$3.80
$2.00K
John Gill
23 Dec 2025
Director
Buy
12,500
$4.10
$51.25K
Jerome Benedict Durso
22 Dec 2025
Director
Buy
12,500
$4.13
$51.57K
Catherine A. Sohn
17 Mar 2025
Director
Buy
1,000
$5.78
$5.78K
Gregory L Weaver
13 Mar 2025
Chief Financial Officer
Buy
10,000
$5.20
$52.00K
David Drutz
19 Aug 2024
Director
Sold after exercise indirect
8,184
$6.88
$56.31K
David Drutz
19 Aug 2024
Director
Sold after exercise indirect
7,827
$6.93
$54.24K
David Drutz
15 Aug 2023
Director
Buy indirect
300
$2.88
$862.50
Richard I Eisenstadt
24 Mar 2023
Chief Financial Officer
Buy
10,000
$4.31
$43.14K
Matthew Scott Harris
23 Mar 2023
Chief Medical Officer
Buy
10,000
$4.22
$42.20K
David Drutz
23 Mar 2023
Director
Buy indirect
9,000
$4.27
$38.43K
Wayne Pisano
22 Dec 2022
Director
Sold after exercise
20,000
$15.01
$300.27K
David Drutz
18 Nov 2022
Director
Exercised, kept
139
$2.40
$333.60
Vipin K Garg
31 Aug 2022
President and CEO
Sell
20,000
$20.02
$400.32K
Vipin K Garg
12 Aug 2022
President and CEO
Sell
15,000
$15.06
$225.89K
John Gill
12 Aug 2022
Director
Sell
2,714
$15.00
$40.71K
M Scot Roberts
5 Jul 2022
Chief Scientific Officer
Sold after exercise
10,182
$12.00
$122.18K
M Scot Roberts
1 Jul 2022
Chief Scientific Officer
Sold after exercise
26,982
$12.00
$323.78K
M Scot Roberts
29 Jun 2022
Chief Scientific Officer
Sold after exercise
5,462
$12.00
$65.55K
Diane Jorkasky
27 Jun 2022
Director
Sold after exercise
17,610
$11.75
$206.94K
M Scot Roberts
27 Jun 2022
Chief Scientific Officer
Sold after exercise
37,352
$12.00
$448.25K
Klaus Schafer
20 Jun 2022
Director
Exercised, kept
60
$2.40
$144.00
Klaus Schafer
20 Jun 2022
Director
Exercised, kept
159
$2.40
$381.60
Klaus Schafer
20 Jun 2022
Director
Exercised, kept
60
$2.40
$144.00
David Drutz
15 Jun 2022
Director
Buy
1,000
$8.00
$8.00K
David Drutz
24 May 2022
Director
Buy
1,200
$4.50
$5.40K
Matthew Scott Harris
28 Feb 2022
Chief Medical Officer
Sold after exercise
30,000
$7.52
$225.60K
David Drutz
25 Jan 2022
Director
Exercised, kept
70
$2.40
$168.00
David Drutz
14 Dec 2021
Director
Exercised, kept
139
$2.40
$333.60
David Drutz
19 Nov 2021
Director
Exercised, kept
70
$2.40
$168.00
Philip Hodges
1 Mar 2021
Director
Sell
6,000
$16.08
$96.48K
Klaus Schafer
10 Dec 2020
Director
Buy
2,000
$11.99
$23.98K
Philip Hodges
1 Dec 2020
Director
Sell indirect
1,227
$13.54
$16.61K
John Gill
30 Nov 2020
Director
Sell
8,425
$11.92
$100.43K
Philip Hodges
30 Nov 2020
Director
Sell
2,500
$12.00
$30.00K
David Drutz
13 Nov 2020
Director
Exercised, kept
60
$2.40
$144.00
Matthew Scott Harris
12 Nov 2020
Director
Sell
4,015
$10.02
$40.23K
Wayne Pisano
12 Nov 2020
Director
Sell
10,352
$9.90
$102.48K
Klaus Schafer
12 Nov 2020
Director
Sell
10,150
$9.91
$100.59K
Venrock Healthcare Capital Partners III, L.P.
15 Jun 2020
10% owner
Buy indirect
1,500,000
$7.54
$11.31M
Venrock Healthcare Capital Partners III, L.P.
28 May 2020
10% owner
Buy indirect
173,711
$8.87
$1.54M
Venrock Healthcare Capital Partners III, L.P.
28 May 2020
10% owner
Buy indirect
27,763
$7.79
$216.27K
Venrock Healthcare Capital Partners III, L.P.
27 May 2020
10% owner
Buy indirect
277,000
$7.92
$2.19M
Venrock Healthcare Capital Partners III, L.P.
27 May 2020
10% owner
Buy indirect
125,162
$7.23
$904.92K
Venrock Healthcare Capital Partners III, L.P.
26 May 2020
10% owner
Buy indirect
390,547
$9.78
$3.82M
Venrock Healthcare Capital Partners III, L.P.
26 May 2020
10% owner
Buy indirect
309,453
$8.79
$2.72M
Velocity Pharmaceutical Holdings LLC
15 May 2020
10% owner
Sell
30,622
$4.65
$142.39K
Velocity Pharmaceutical Holdings LLC
14 May 2020
10% owner
Sell
169,378
$4.81
$814.71K
Vipin K Garg
5 Sep 2019
President and CEO
Buy
20,000
$2.10
$42.00K
Wayne Pisano
9 Oct 2018
Director
Buy
2,000
$4.59
$9.18K
William Enright
25 May 2018
President and CEO
Buy
1,300
$0.51
$659.88
M Scot Roberts
21 May 2018
Chief Scientific Officer
Exercised, kept
55,120
$0.08
$4.41K
William Enright
2 Jan 2018
President and CEO
Exercised, kept
183,347
$0.08
$14.67K
Derace L Schaffer
29 Dec 2017
Director
Buy
38,699
$1.93
$74.78K
Mitchel Sayare
29 Dec 2017
Director
Buy indirect
5,100
$1.95
$9.96K
Derace L Schaffer
28 Dec 2017
Director
Buy
58,711
$1.92
$112.67K
Derace L Schaffer
27 Dec 2017
Director
Buy
27,706
$1.77
$49.04K
Derace L Schaffer
27 Dec 2017
Director
Buy
50,000
$1.76
$88.17K
Derace L Schaffer
26 Dec 2017
Director
Buy
51,442
$1.81
$93.27K
Derace L Schaffer
22 Dec 2017
Director
Buy
17,982
$1.61
$28.88K
Derace L Schaffer
7 Dec 2017
Director
Buy
7,639
$1.74
$13.31K
Derace L Schaffer
6 Dec 2017
Director
Buy
16,106
$1.80
$29.00K
Derace L Schaffer
5 Dec 2017
Director
Buy
13,495
$1.78
$23.99K
Derace L Schaffer
4 Dec 2017
Director
Buy
7,300
$1.81
$13.20K
Derace L Schaffer
1 Dec 2017
Director
Buy
5,215
$1.80
$9.40K
Derace L Schaffer
30 Nov 2017
Director
Buy
12,978
$1.84
$23.82K
Derace L Schaffer
29 Nov 2017
Director
Buy
7,942
$1.94
$15.38K
Derace L Schaffer
28 Nov 2017
Director
Buy
12,395
$1.97
$24.45K
Derace L Schaffer
27 Nov 2017
Director
Buy
10,042
$2.00
$20.06K
Derace L Schaffer
24 Nov 2017
Director
Buy
6,505
$2.02
$13.16K
Derace L Schaffer
22 Nov 2017
Director
Buy
5,261
$2.10
$11.06K
Derace L Schaffer
21 Nov 2017
Director
Buy
7,236
$2.06
$14.91K
Derace L Schaffer
20 Nov 2017
Director
Buy
4,800
$2.07
$9.96K
Derace L Schaffer
17 Nov 2017
Director
Buy
6,295
$2.12
$13.35K
Derace L Schaffer
25 Aug 2017
Director
Buy
50,000
$2.25
$112.39K
Derace L Schaffer
24 Aug 2017
Director
Buy
17,326
$2.24
$38.89K
Derace L Schaffer
23 Aug 2017
Director
Buy
43,352
$2.22
$96.35K
David Drutz
23 Aug 2017
Director
Buy
5,000
$2.27
$11.34K
Derace L Schaffer
22 Aug 2017
Director
Buy
5,958
$2.10
$12.52K
David Drutz
22 Aug 2017
Director
Buy
5,000
$2.15
$10.76K
Derace L Schaffer
21 Aug 2017
Director
Buy
690
$2.02
$1.39K
William Enright
16 Aug 2017
President and CEO
Exercised, kept
91,733
$0.08
$7.34K
William Enright
16 Aug 2017
President and CEO
Exercised, kept
71,644
$0.08
$5.73K
M Scot Roberts
6 Jun 2017
Chief Scientific Officer
Buy indirect
449
$4.42
$1.98K
John Gill
2 Jun 2017
Director
Buy
1,000
$4.34
$4.34K
Jeffrey W. Runge
20 Jan 2017
Director
Exercised, kept
20,000
$3.11
$62.20K
Derace L Schaffer
13 Jan 2017
Director
Exercised, kept
20,000
$2.20
$44.00K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
20,000
$2.20
$44.00K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
20,000
$3.11
$62.20K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
20,000
$2.47
$49.40K
Peter Steven St
4 Jan 2017
Director
Exercised, kept
10,000
$2.59
$25.90K
Philip Macneill
21 Dec 2016
VP, CFO, Treasurer, Secretary
Exercised, kept
17,657
$1.66
$29.31K
Philip Macneill
21 Dec 2016
VP, CFO, Treasurer, Secretary
Exercised, kept
5,000
$1.71
$8.55K
Prescott Group Capital Management, L.l.c.
9 Dec 2016
10% owner
Sell indirect
436,324
$3.26
$1.42M
Prescott Group Capital Management, L.l.c.
8 Dec 2016
10% owner
Sell indirect
440,479
$3.25
$1.43M
Prescott Group Capital Management, L.l.c.
7 Dec 2016
10% owner
Sell indirect
477,829
$3.26
$1.56M
Jeffrey W. Runge
28 Nov 2016
Director
Exercised, kept
20,000
$2.20
$44.00K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
20,000
$2.20
$44.00K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
20,000
$1.69
$33.80K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
135,660
$1.71
$231.98K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
240,000
$1.94
$465.60K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
37,500
$1.19
$44.63K
Eric I Richman
22 Nov 2016
Director
Exercised, kept
30,573
$2.46
$75.21K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$2.20
$44.00K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.69
$33.80K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
18,361
$1.81
$33.23K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.51
$30.20K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.64
$32.80K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.45
$29.00K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
52,139
$2.67
$139.21K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
60,000
$2.67
$160.20K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.60
$32.00K
Mitchel Sayare
22 Nov 2016
Director
Exercised, kept
20,000
$1.52
$30.40K
John Gill
22 Nov 2016
President and CEO
Exercised, kept
100,000
$2.20
$220.00K

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 13,705,868
Sales filed before the plan box existed 14
History held since 7 May 2007